WallStSmart
BMEA

Biomea Fusion Inc

NASDAQ: BMEA · HEALTHCARE · BIOTECHNOLOGY

$1.43
-5.11% today

Updated 2026-06-03

Market cap
$99.05M
P/E ratio
P/S ratio
EPS (TTM)
$-0.55
Dividend yield
52W range
$1 – $3
Volume
1.6M

Biomea Fusion Inc (BMEA) Financial statements

SEC filings — annual and quarterly data.

Cash flow — annual

Item2019202020212022202320242025
Operating cash flow$-1.28M$-4.46M$-35.44M$-62.42M$-96.59M$-119.89M$-70.37M
Capital expenditures$51000.00$51000.00$3.17M$1.03M$3.37M$362000.00$0.00
Depreciation
Stock-based comp$0.00$322000.00$6.23M$10.34M$14.13M$19.09M$9.52M
Free cash flow$-1.33M$-4.51M$-38.61M$-63.45M$-99.96M$-120.26M$-70.37M
Investing cash flow
Financing cash flow
Dividends paid
Share repurchases
Debt repayment
Net change in cash$84.39M$-33.84M

Frequently asked questions

How much free cash flow does BMEA generate?

BMEA produced $-70.37M in free cash flow in its most recent fiscal year. Free cash flow is what is left after running and reinvesting in the business, and it is the cash that actually funds buybacks, dividends, and a stronger balance sheet.

Is BMEA's balance sheet healthy?

BMEA holds $55.81M in cash and equivalents against — in long-term debt, on $29.55M of shareholder equity. That debt is best read against the cash flow the business throws off each year.